Screener / SEC EDGAR /CIK 0001125376 /10-K filed Feb 4, 2026, compared with Feb 5, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Skilled Nursing Care Facilities

Ensign Group, Inc ENSG

Compare with peers Embed

ENSG among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
+18.7%45th of 155 · median +10.5%
Net margin
-4.1%15.3%
7.0%75th of 154 · median 6.8%
Return on equity
-5.2%18.5%
15.6%46th of 144 · median 9.2%
Debt / equity (less is better)
1.160.42
0.089th of 108 · median 0.69

ENSG and 9 peers, year by year

The 9 Health care companies closest to ENSG in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
ENSG Ensign Group, Inc FY2025 $5.1B+18.8%-8.4%6.8%-15.4%0.06
RMD ResMed FY2026 $5.7B+9.9%61.1%33.4%26.9%29.2%23.1%0.10
WAT Waters Corporation FY2025 $3.2B+7.0%-25.4%20.3%17.1%25.1%0.55
OPCH Option Care Health, Inc. FY2025 $5.6B+13.0%19.3%6.0%3.7%3.8%15.7%0.88
INCY Incyte FY2025 $5.1B+21.2%-29.5%25.0%-24.9%-
OGN Organon & Co. FY2025 $6.2B−2.9%53.3%-3.0%8.7%24.9%11.52
STE Steris FY2026 $5.9B+8.7%44.2%18.6%13.2%16.4%10.9%0.27
ELAN Elanco Animal Health Inc FY2025 $4.7B+6.2%55.0%-−4.9%6.0%−3.5%0.57
DXCM Dexcom FY2025 $4.7B+15.6%60.1%19.6%17.9%23.1%30.5%-
ALNY Alnylam Pharmaceuticals, Inc. FY2025 $3.7B+65.2%-13.5%8.4%12.5%39.8%-

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

ENSGEnsign Group, Inc
FY2016 revenue $1.7BFY2017 revenue $1.6BFY2018 revenue $1.8BFY2019 revenue $2.0BFY2020 revenue $2.4BFY2021 revenue $2.6BFY2022 revenue $3.0BFY2023 revenue $3.7BFY2024 revenue $4.3BFY2025 revenue $5.1B FY2016 net margin 3.0%FY2017 net margin 2.5%FY2018 net margin 5.3%FY2019 net margin 5.4%FY2020 net margin 7.1%FY2021 net margin 7.4%FY2022 net margin 7.4%FY2023 net margin 5.6%FY2024 net margin 7.0%FY2025 net margin 6.8% FY2016FY2025
Revenue$5.1B Growth+18.8% Net margin6.8%
RMDResMed
FY2016 revenue $1.8BFY2017 revenue $2.1BFY2018 revenue $2.3BFY2019 revenue $2.6BFY2020 revenue $3.0BFY2021 revenue $3.2BFY2022 revenue $3.6BFY2023 revenue $4.2BFY2024 revenue $4.7BFY2025 revenue $5.1B FY2016 net margin 19.2%FY2017 net margin 16.6%FY2018 net margin 13.5%FY2019 net margin 15.5%FY2020 net margin 21.0%FY2021 net margin 14.8%FY2022 net margin 21.8%FY2023 net margin 21.3%FY2024 net margin 21.8%FY2025 net margin 27.2% FY2016FY2025
Revenue$5.1B Growth+9.8% Net margin27.2%
WATWaters Corporation
FY2016 revenue $2.2BFY2017 revenue $2.3BFY2018 revenue $2.4BFY2019 revenue $2.4BFY2020 revenue $2.4BFY2021 revenue $2.8BFY2022 revenue $3.0BFY2023 revenue $3.0BFY2024 revenue $3.0BFY2025 revenue $3.2B FY2016 net margin 24.1%FY2017 net margin 0.9%FY2018 net margin 24.5%FY2019 net margin 24.6%FY2020 net margin 22.1%FY2021 net margin 24.9%FY2022 net margin 23.8%FY2023 net margin 21.7%FY2024 net margin 21.6%FY2025 net margin 20.3% FY2016FY2025
Revenue$3.2B Growth+7.0% Net margin20.3%
OPCHOption Care Health, Inc.
FY2016 revenue $935.6MFY2017 revenue $1.8BFY2018 revenue $1.9BFY2019 revenue $2.3BFY2020 revenue $3.0BFY2021 revenue $3.4BFY2022 revenue $3.9BFY2023 revenue $4.3BFY2024 revenue $5.0BFY2025 revenue $5.6B FY2016 net margin −4.6%FY2017 net margin 0.2%FY2018 net margin −0.3%FY2019 net margin −3.3%FY2020 net margin −0.3%FY2021 net margin 4.1%FY2022 net margin 3.8%FY2023 net margin 6.2%FY2024 net margin 4.2%FY2025 net margin 3.7% FY2016FY2025
Revenue$5.6B Growth+13.0% Net margin3.7%
INCYIncyte
FY2016 revenue $1.1BFY2017 revenue $1.5BFY2018 revenue $1.9BFY2019 revenue $2.2BFY2020 revenue $2.7BFY2021 revenue $3.0BFY2022 revenue $3.4BFY2023 revenue $3.7BFY2024 revenue $4.2BFY2025 revenue $5.1B FY2016 net margin 9.4%FY2017 net margin −20.4%FY2018 net margin 5.8%FY2019 net margin 20.7%FY2020 net margin −11.1%FY2021 net margin 31.8%FY2022 net margin 10.0%FY2023 net margin 16.2%FY2024 net margin 0.8%FY2025 net margin 25.0% FY2016FY2025
Revenue$5.1B Growth+21.2% Net margin25.0%
OGNOrganon & Co.
FY2019 revenue $7.8BFY2020 revenue $6.5BFY2021 revenue $6.3BFY2022 revenue $6.2BFY2023 revenue $6.3BFY2024 revenue $6.4BFY2025 revenue $6.2B FY2019 net margin 41.4%FY2020 net margin 33.1%FY2021 net margin 21.4%FY2022 net margin 14.9%FY2023 net margin 16.3%FY2024 net margin 13.5%FY2025 net margin 3.0% FY2016FY2025
Revenue$6.2B Growth−2.9% Net margin3.0%
STESteris
FY2017 revenue $2.6BFY2018 revenue $2.6BFY2019 revenue $2.8BFY2020 revenue $3.0BFY2021 revenue $3.1BFY2022 revenue $4.2BFY2023 revenue $4.5BFY2024 revenue $5.1BFY2025 revenue $5.5B FY2017 net margin 4.2%FY2018 net margin 11.1%FY2019 net margin 10.9%FY2020 net margin 13.5%FY2021 net margin 12.8%FY2022 net margin 5.8%FY2023 net margin 2.4%FY2024 net margin 7.4%FY2025 net margin 11.3% FY2016FY2025
Revenue$5.5B Growth+6.2% Net margin11.3%
ELANElanco Animal Health Inc
FY2016 revenue $2.9BFY2017 revenue $2.9BFY2018 revenue $3.1BFY2019 revenue $3.1BFY2020 revenue $3.3BFY2021 revenue $4.8BFY2022 revenue $4.4BFY2023 revenue $4.4BFY2024 revenue $4.4BFY2025 revenue $4.7B FY2016 net margin −1.6%FY2017 net margin −10.8%FY2018 net margin 2.8%FY2019 net margin 2.2%FY2020 net margin −17.5%FY2021 net margin −10.1%FY2022 net margin −1.8%FY2023 net margin −27.9%FY2024 net margin 7.6%FY2025 net margin −4.9% FY2016FY2025
Revenue$4.7B Growth+6.2% Net margin−4.9%
DXCMDexcom
FY2016 revenue $573.3MFY2017 revenue $718.5MFY2018 revenue $1.0BFY2019 revenue $1.5BFY2020 revenue $1.9BFY2021 revenue $2.4BFY2022 revenue $2.9BFY2023 revenue $3.6BFY2024 revenue $4.0BFY2025 revenue $4.7B FY2016 net margin −11.4%FY2017 net margin −7.0%FY2018 net margin −12.3%FY2019 net margin 6.8%FY2020 net margin 28.5%FY2021 net margin 8.9%FY2022 net margin 11.7%FY2023 net margin 14.9%FY2024 net margin 14.3%FY2025 net margin 17.9% FY2016FY2025
Revenue$4.7B Growth+15.6% Net margin17.9%
ALNYAlnylam Pharmaceuticals, Inc.
FY2016 revenue $47.2MFY2017 revenue $89.9MFY2018 revenue $74.9MFY2019 revenue $219.8MFY2020 revenue $492.9MFY2021 revenue $844.3MFY2022 revenue $1.0BFY2023 revenue $1.8BFY2024 revenue $2.2BFY2025 revenue $3.7B FY2016 net margin −869.6%FY2017 net margin −545.9%FY2019 net margin −403.2%FY2020 net margin −174.1%FY2021 net margin −101.0%FY2022 net margin −109.0%FY2023 net margin −24.1%FY2024 net margin −12.4%FY2025 net margin 8.4% FY2016FY2025
Revenue$3.7B Growth+65.2% Net margin8.4%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

100 500 2000 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: $1.8B, $2.1B, $2.3B, $2.6B, $3.0B, $3.2B, $3.6B, $4.2B, $4.7B, $5.1B RMD WAT: $2.2B, $2.3B, $2.4B, $2.4B, $2.4B, $2.8B, $3.0B, $3.0B, $3.0B, $3.2B WAT OPCH: $935.6M, $1.8B, $1.9B, $2.3B, $3.0B, $3.4B, $3.9B, $4.3B, $5.0B, $5.6B OPCH INCY: $1.1B, $1.5B, $1.9B, $2.2B, $2.7B, $3.0B, $3.4B, $3.7B, $4.2B, $5.1B INCY OGN: -, -, -, $7.8B, $6.5B, $6.3B, $6.2B, $6.3B, $6.4B, $6.2B OGN STE: -, $2.6B, $2.6B, $2.8B, $3.0B, $3.1B, $4.2B, $4.5B, $5.1B, $5.5B STE ELAN: $2.9B, $2.9B, $3.1B, $3.1B, $3.3B, $4.8B, $4.4B, $4.4B, $4.4B, $4.7B ELAN DXCM: $573.3M, $718.5M, $1.0B, $1.5B, $1.9B, $2.4B, $2.9B, $3.6B, $4.0B, $4.7B DXCM ALNY: $47.2M, $89.9M, $74.9M, $219.8M, $492.9M, $844.3M, $1.0B, $1.8B, $2.2B, $3.7B ALNY ENSG: $1.7B, $1.6B, $1.8B, $2.0B, $2.4B, $2.6B, $3.0B, $3.7B, $4.3B, $5.1B ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. A ring marks where a line starts: OGN, STE have no earlier 10-K here. ENSG, OPCH: the line is cut where a later 10-K restates the year before (a spin-off or a merger), so the two years are not the same company.

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

−16.7% +193% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: -, +12.4%, +13.2%, +11.4%, +13.4%, +8.1%, +11.9%, +18.0%, +10.9%, +9.8% RMD WAT: +6.1%, +6.5%, +4.8%, −0.6%, −1.7%, +17.8%, +6.7%, −0.5%, +0.1%, +7.0% WAT OPCH: -, −12.7%, +6.1%, +19.1%, +31.3%, +13.4%, +14.7%, +9.1%, +16.2%, +13.0% OPCH INCY: +46.7%, +38.9%, +22.5%, +14.7%, +23.5%, +12.0%, +13.7%, +8.9%, +14.8%, +21.2% INCY OGN: -, -, -, -, −16.0%, −3.5%, −2.1%, +1.4%, +2.2%, −2.9% OGN STE: -, -, +0.3%, +6.2%, +8.9%, +2.5%, +47.5%, +7.4%, +13.3%, +6.2% STE ELAN: -, −0.8%, +6.2%, +0.1%, +6.6%, +45.6%, −7.4%, +0.1%, +0.5%, +6.2% ELAN DXCM: +42.6%, +25.3%, +43.6%, +43.1%, +30.5%, +27.1%, +18.8%, +24.5%, +11.3%, +15.6% DXCM ALNY: -, +90.7%, −16.7%, +193%, +124%, +71.3%, +22.9%, +76.2%, +23.0%, +65.2% ALNY ENSG: +23.3%, +11.8%, +9.8%, +16.1%, +18.0%, +9.4%, +15.1%, +23.3%, +14.3%, +18.8% ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −16.7% to +193%. A gap is a year with no number. A ring marks where a line starts: RMD, OPCH, OGN, STE, ELAN, ALNY have no earlier 10-K here.

Gross margin, FY2016 to FY2025

Gross profit / revenue.

19.3% 68.6% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: 58.0%, 58.1%, 57.0%, 57.3%, 58.1%, 57.5%, 56.6%, 55.8%, 56.7%, 59.4% RMD OPCH: 28.0%, 24.4%, 21.8%, 22.2%, 22.5%, 22.7%, 22.0%, 22.8%, 20.3%, 19.3% OPCH OGN: -, -, -, -, -, -, 62.8%, 59.8%, 58.0%, 53.3% OGN STE: -, 39.3%, 41.7%, 42.2%, 43.6%, 43.2%, 44.6%, 43.7%, 43.2%, 44.0% STE ELAN: -, -, -, -, -, -, -, 56.3%, 54.9%, 55.0% ELAN DXCM: 66.0%, 68.5%, 64.4%, 63.1%, 66.4%, 68.6%, 64.7%, 63.2%, 60.5%, 60.1% DXCM
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 19.3% to 68.6%. A gap is a year with no number. A ring marks where a line starts: OGN, STE, ELAN have no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
ENSG Dec ----------
RMD Jun 58.0%58.1%57.0%57.3%58.1%57.5%56.6%55.8%56.7%59.4%
WAT Dec ----------
OPCH Dec 28.0%24.4%21.8%22.2%22.5%22.7%22.0%22.8%20.3%19.3%
INCY Dec ----------
OGN Dec ------62.8%59.8%58.0%53.3%
STE Mar -39.3%41.7%42.2%43.6%43.2%44.6%43.7%43.2%44.0%
ELAN Dec -------56.3%54.9%55.0%
DXCM Dec 66.0%68.5%64.4%63.1%66.4%68.6%64.7%63.2%60.5%60.1%
ALNY Dec ----------
Peer median58.0%48.7%49.4%49.8%50.8%50.4%56.6%56.0%55.8%54.1%

Operating margin, FY2016 to FY2025

Operating income / revenue.

−900.3% 32.7% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: 23.3%, 20.6%, 23.2%, 22.2%, 27.4%, 28.3%, 28.0%, 26.8%, 28.2%, 32.7% RMD WAT: 28.8%, 28.7%, 30.6%, 29.4%, 27.3%, 29.5%, 29.4%, 27.7%, 27.9%, 25.4% WAT OPCH: −1.2%, 1.5%, 2.0%, 0.0%, 3.7%, 5.5%, 6.1%, 7.3%, 6.4%, 6.0% OPCH INCY: 13.1%, −15.8%, 6.9%, 18.6%, −9.9%, 19.6%, 17.1%, 16.8%, 1.4%, 29.5% INCY STE: -, 8.7%, 15.3%, 14.8%, 17.7%, 17.6%, 11.3%, 17.4%, 16.3%, 15.9% STE DXCM: −11.1%, −5.9%, −18.1%, 9.6%, 15.5%, 10.9%, 13.4%, 16.5%, 14.9%, 19.6% DXCM ALNY: −900.3%, −556.2%, n/m, −427.5%, −168.1%, −83.9%, −75.7%, −15.4%, −7.9%, 13.5% ALNY ENSG: 5.6%, 2.7%, 4.8%, 6.3%, 9.3%, 9.9%, 9.8%, 6.8%, 8.4%, 8.4% ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −900.3% to 32.7%. A gap is a year with no number. A ring marks where a line starts: STE has no earlier 10-K here.

Net margin, FY2016 to FY2025

Net income / revenue.

−869.6% 41.4% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: 19.2%, 16.6%, 13.5%, 15.5%, 21.0%, 14.8%, 21.8%, 21.3%, 21.8%, 27.2% RMD WAT: 24.1%, 0.9%, 24.5%, 24.6%, 22.1%, 24.9%, 23.8%, 21.7%, 21.6%, 20.3% WAT OPCH: −4.6%, 0.2%, −0.3%, −3.3%, −0.3%, 4.1%, 3.8%, 6.2%, 4.2%, 3.7% OPCH INCY: 9.4%, −20.4%, 5.8%, 20.7%, −11.1%, 31.8%, 10.0%, 16.2%, 0.8%, 25.0% INCY OGN: -, -, -, 41.4%, 33.1%, 21.4%, 14.9%, 16.3%, 13.5%, 3.0% OGN STE: -, 4.2%, 11.1%, 10.9%, 13.5%, 12.8%, 5.8%, 2.4%, 7.4%, 11.3% STE ELAN: −1.6%, −10.8%, 2.8%, 2.2%, −17.5%, −10.1%, −1.8%, −27.9%, 7.6%, −4.9% ELAN DXCM: −11.4%, −7.0%, −12.3%, 6.8%, 28.5%, 8.9%, 11.7%, 14.9%, 14.3%, 17.9% DXCM ALNY: −869.6%, −545.9%, n/m, −403.2%, −174.1%, −101.0%, −109.0%, −24.1%, −12.4%, 8.4% ALNY ENSG: 3.0%, 2.5%, 5.3%, 5.4%, 7.1%, 7.4%, 7.4%, 5.6%, 7.0%, 6.8% ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −869.6% to 41.4%. A gap is a year with no number. A ring marks where a line starts: OGN, STE have no earlier 10-K here.

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

−$718.1M $2.9B FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: $489.4M, $351.8M, $442.4M, $390.3M, $706.9M, $634.0M, $216.3M, $573.6M, $1.3B, $1.7B RMD WAT: -, -, -, -, -, -, -, $442.2M, $619.6M, $539.8M WAT OPCH: -, $12.9M, −$1.8M, $11.2M, $100.5M, $182.9M, $232.2M, $329.4M, $287.8M, $217.1M OPCH INCY: $184.5M, −$204.0M, $262.7M, $632.6M, −$312.0M, $568.5M, $892.1M, -, -, - INCY OGN: -, -, -, $2.9B, $2.0B, $2.0B, $662.0M, $548.0M, $764.0M, $538.0M OGN STE: -, $251.2M, $292.2M, $349.8M, $376.0M, $450.4M, $397.2M, $395.0M, $613.0M, $778.0M STE ELAN: $45.6M, $75.2M, $352.8M, $84.0M, −$176.0M, $324.0M, $281.0M, $131.0M, $394.0M, $284.0M ELAN DXCM: $500K, $26.0M, $56.1M, $134.5M, $276.6M, $53.3M, $304.7M, $511.9M, $630.7M, $1.1B DXCM ALNY: −$372.3M, −$487.0M, −$689.5M, −$418.6M, −$685.3M, −$718.1M, −$613.3M, $41.9M, −$42.6M, $465.4M ALNY ENSG: $8.2M, $25.5M, $159.4M, $120.7M, -, -, -, -, -, - ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$718.1M to $2.9B. A gap is a year with no number. A ring marks where a line starts: WAT, OPCH, OGN, STE have no earlier 10-K here.

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

−920.5% 37.6% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: 26.6%, 17.0%, 18.9%, 15.0%, 23.9%, 19.8%, 6.0%, 13.6%, 27.8%, 32.3% RMD WAT: -, -, -, -, -, -, -, 15.0%, 20.9%, 17.1% WAT OPCH: -, 0.7%, −0.1%, 0.5%, 3.3%, 5.3%, 5.9%, 7.7%, 5.8%, 3.8% OPCH INCY: 16.7%, −13.3%, 14.0%, 29.3%, −11.7%, 19.0%, 26.3%, -, -, - INCY OGN: -, -, -, 37.6%, 31.1%, 31.2%, 10.7%, 8.7%, 11.9%, 8.7% OGN STE: -, 9.6%, 11.2%, 12.6%, 12.4%, 14.5%, 9.4%, 8.7%, 11.9%, 14.3% STE ELAN: 1.6%, 2.6%, 11.5%, 2.7%, −5.4%, 6.8%, 6.4%, 3.0%, 8.9%, 6.0% ELAN DXCM: 0.1%, 3.6%, 5.4%, 9.1%, 14.4%, 2.2%, 10.5%, 14.1%, 15.6%, 23.1% DXCM ALNY: −789.4%, −541.6%, −920.5%, −190.5%, −139.1%, −85.0%, −59.1%, 2.3%, −1.9%, 12.5% ALNY ENSG: 0.5%, 1.6%, 9.1%, 5.9%, -, -, -, -, -, - ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −920.5% to 37.6%. A gap is a year with no number. A ring marks where a line starts: WAT, OPCH, OGN, STE have no earlier 10-K here.

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

−145.0% 188.5% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: 20.8%, 17.5%, 15.3%, 19.5%, 24.9%, 16.4%, 23.2%, 21.7%, 21.0%, 23.5% RMD WAT: 22.7%, 0.9%, 37.9%, n/m, n/m, 188.5%, 140.3%, 55.8%, 34.9%, 25.1% WAT OPCH: −7.1%, 0.6%, −1.0%, −8.4%, −0.8%, 11.9%, 10.9%, 18.8%, 15.1%, 15.7% OPCH INCY: 24.8%, −19.2%, 5.7%, 17.2%, −11.3%, 25.2%, 7.8%, 11.5%, 0.9%, 24.9% INCY OGN: -, -, -, 45.7%, 39.4%, n/m, n/m, n/m, 183.1%, 24.9% OGN STE: -, 3.9%, 9.1%, 9.6%, 12.0%, 10.2%, 3.7%, 1.8%, 6.0%, 9.3% STE ELAN: −0.7%, −4.0%, 1.7%, 1.2%, −6.8%, −6.4%, −1.1%, −19.8%, 5.5%, −3.5% ELAN DXCM: −23.1%, −12.0%, −19.2%, 11.5%, 35.4%, 10.6%, 16.0%, 26.2%, 27.4%, 30.5% DXCM ALNY: −44.6%, −27.8%, −58.5%, −61.6%, −84.5%, −145.0%, n/m, n/m, n/m, 39.8% ALNY ENSG: 11.0%, 8.2%, 15.6%, 16.9%, 20.8%, 19.1%, 18.0%, 14.0%, 16.2%, 15.4% ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −145.0% to 188.5%. A gap is a year with no number. A ring marks where a line starts: OGN, STE have no earlier 10-K here.

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

0.00 18.81 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: 0.69, 0.55, 0.14, 0.61, 0.47, 0.23, 0.23, 0.35, 0.15, 0.11 RMD WAT: 0.85, 0.89, 0.73, n/m, 5.86, 4.14, 3.13, 2.05, 0.89, 0.55 WAT OPCH: 0.78, 0.83, 0.89, 1.42, 1.11, 0.91, 0.77, 0.75, 0.79, 0.88 OPCH INCY: 1.79, 0.02, 9.91, -, -, -, -, -, -, - INCY OGN: -, -, -, -, 0.00, n/m, n/m, n/m, 18.81, 11.52 OGN STE: -, -, 0.41, 0.37, 0.34, 0.43, 0.47, 0.51, 0.51, 0.31 STE ELAN: -, 0.00, 0.48, 0.42, 0.72, 0.84, 0.80, 0.93, 0.71, 0.57 ELAN ALNY: -, -, -, -, 0.19, 1.15, -, -, -, - ALNY ENSG: 0.62, 0.64, 0.42, 0.50, 0.14, 0.16, 0.13, 0.10, 0.08, 0.06 ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 18.81. A gap is a year with no number. A ring marks where a line starts: OGN, STE, ELAN, ALNY have no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
ENSG Dec 0.620.640.420.500.140.160.130.100.080.06
RMD Jun 0.690.550.140.610.470.230.230.350.150.11
WAT Dec 0.850.890.73n/m5.864.143.132.050.890.55
OPCH Dec 0.780.830.891.421.110.910.770.750.790.88
INCY Dec 1.790.029.91-------
OGN Dec ----0.00n/mn/mn/m18.8111.52
STE Mar --0.410.370.340.430.470.510.510.31
ELAN Dec -0.000.480.420.720.840.800.930.710.57
DXCM Dec ----------
ALNY Dec ----0.191.15----
Peer median0.810.550.600.520.470.870.770.750.750.56

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

−$9.30 $12.69 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 RMD: $2.49, $2.40, $2.19, $2.80, $4.27, $3.24, $5.30, $6.09, $6.92, $9.51 RMD WAT: $6.41, $0.25, $7.65, $8.69, $8.36, $11.17, $11.73, $10.84, $10.71, $10.76 WAT OPCH: −$0.55, $0.03, −$0.04, −$0.49, −$0.04, $0.77, $0.83, $1.48, $1.23, $1.27 OPCH INCY: $0.54, −$1.53, $0.51, $2.05, −$1.36, $4.27, $1.52, $2.65, $0.15, $6.41 INCY OGN: -, -, -, $12.69, $8.52, $5.31, $3.59, $3.99, $3.33, $0.72 OGN STE: -, $1.28, $3.39, $3.55, $4.76, $4.63, $2.48, $1.07, $3.81, $6.20 STE ELAN: −$0.16, −$1.06, $0.28, $0.18, −$1.30, −$0.99, −$0.16, −$2.50, $0.68, −$0.47 ELAN DXCM: −$0.78, −$0.58, −$1.44, $1.10, $1.33, $0.53, $0.82, $1.30, $1.42, $2.09 DXCM ALNY: −$4.79, −$5.42, −$7.57, −$8.11, −$7.46, −$7.20, −$9.30, −$3.52, −$2.18, $2.33 ALNY ENSG: $0.96, $0.77, $1.70, $1.97, $3.06, $3.42, $3.95, $3.65, $5.12, $5.84 ENSG
ENSG is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$9.30 to $12.69. A gap is a year with no number. A ring marks where a line starts: OGN, STE have no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out ENSG and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: ENSG's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ENSG/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.